The global bone regeneration market is projected to achieve a valuation of USD 5,380.75 million in 2023, with expectations to expand to USD 7,827.8 million by 2033. This growth reflects a compound annual growth rate (CAGR) of 3.8% over the forecast period.
Bone graft substitutes have maintained a leading position in the market, commanding an impressive 81.2% share in 2022. Their dominance underscores the critical role these products play in advancing bone regeneration treatments and procedures.
As the industry continues to evolve, innovations in bone regeneration technologies and the increasing prevalence of bone-related conditions are driving the market’s steady growth. This expansion highlights the ongoing advancements and the significant potential for future developments in the bone regeneration sector.
Additionally, as the per-care cost is continuing to rise each year, increasing global health spending, the treatment slot gacor for these conditions contributes to the overall cost of pharmaceutical charges. The improved reimbursement scenario covers orthopaedic sector treatment. Medicare, for instance, spent US$ 799.4 billion in 2019 on benefit payments for roughly 61 million people who were 65, older, or disabled.
Medicaid, on the other hand, spent US$138.7 billion on acute care services like hospitalization, visits to the doctor, and prescribed medications in the same year. More patients can choose the treatment when there is a better reimbursement scenario. Future growth in the market for bone regeneration is projected because this factor, is positive. The demand for bone regeneration is expected to rise during the forecast period due to the development of novel, advanced technologies.
Key Takeaways from Bone Regeneration Study
- Bone grafts substitute as products are expected to hold around 83.4% market value share by the end of 2032, and are expected to display a CAGR growth of 4.1% over the forecast period.
- By application, trauma cases hold a dominant market share value of 22.6% in 2021 in the global market. As trauma is the most common cause of death it leads to a positive growth during the forecast period.
- By age group, the adult segment holds a dominant market share value of 56.8% in 2021 in the global market.
- Hospitals hold a higher end-user segment share in terms of the market share value of 49.1% in 2021. Most surgeries need a proper operating environment because it is critical and time-consuming. To ensure patient safety, most surgeries take place in hospitals.
- North America is slated to be the largest leading region with an estimated market value of 39.0% at the end of the forecast period. Owing to the high prevalence of joint diseases in the region.
“Increasing prevalence of orthopedic diseases, rising incidence of bone fractures is expected to drive demand for bone regeneration market during the next decade,” says the FMI Analyst
Market Competition
The market for bone regeneration is moderately fragmented, and there exist, several local, emerging, as well as established players within the market sphere. Key players have initiated promotional activities to introduce new products with continued collaboration and expansion activities
- Johnson & Johnson gained 510(k) FDA clearance in November 2021 for the VELYSTM Robotic-Assisted Solution for use with the ATTUNE® Total Knee System, giving surgeons the chance to streamline their current workflows on a typical orthopedic procedure.
- Altapore Shape bioactive bone graft, the newest addition to Baxter’s line of next-generation bone graft substitutes, was approved by the U.S. Food and Drug Administration (FDA) in September 2020.
Key Players:
- Medtronic plc.
- Stryker Corporation
- DePuy Synthes, Inc.
- Integra Lifesciences Holdings Corporation
- Zimmer Biomet Holdings, Inc.
- Xtant Medical Holdings, Inc.
- Arthrex, Inc.
- Baxter International Inc.
- Musculoskeletal Transplant Foundation
- Smith & Nephew, Inc.
- Orthofix Holdings, Inc.
- Nuvasive, Inc.
- Allosource
- NovaBone Products, LLC
- BonAlive Biomaterials Ltd.
- Sigma Graft Biomaterials
- RTI Surgical
- Institut Straumann AG
- Exactech, Inc
- A.B. Dental Devices Ltd
- Geistlich Pharma AG
- BMT Group
- Osstem Implant
A Old Full Report Analysis Click Here
Key Market Segments Covered in Bone Regeneration Industry Research
By Product:
- Bone Grafts Substitutes
- Allografts
- Demineralized Bone Matrix(DBM)
- Others
- Xenograft
- Autografts
- Synthetic Bone Graft
- Bone Morphogenetic Protein(BMP)
- Allografts
- Bone Growth Stimulators
- Non-Invasive Electrical Bone Growth Stimulators
- Invasive Electrical Bone Growth Stimulators
By Application:
- Osteoarthritis (OA)
- Osteoporosis
- Rheumatoid Arthritis (RA)
- Spinal Disorders
- Dentistry
- Craniomaxillofacial (CMF)
- Trauma Cases
By Age Group:
- Pediatric
- Adults
- Geriatric
By End User:
- Hospitals
- Orthopedic Clinics
- Ambulatory Surgical Centers
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
